Omega-3 and depression
This article was originally published in The Tan Sheet
Executive Summary
Although results of a meta-analysis shows omega-3 polyunsaturated fatty acids demonstrate a significant antidepressant efficacy, the finding cannot be validated due to publication bias and heterogeneity, according to authors of the meta-analysis published in the July Journal of Clinical Psychology. The research was based on 10 double-blind, placebo-controlled studies in patients with mood disorders receiving omega-3 PUFAs with the treatment period lasting four weeks or longer. "More large-scale, well-controlled studies are warranted to find out the favorable target subjects, the optimal composition and the dosage of EPA and DHA, and the long-term efficacy of omega-3 fatty acids in treating depression," say Pao-Yen Lin, Department of Psychiatry, Change Gung Memorial Hospital-Kaohsiung Medical Center, Taiwan, et al...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.